Anti-ZMPSTE24 antibody - Carboxyterminal end (ab70952)


  • Product nameAnti-ZMPSTE24 antibody - Carboxyterminal end
    See all ZMPSTE24 primary antibodies
  • Description
    Rabbit polyclonal to ZMPSTE24 - Carboxyterminal end
  • Tested applicationsSuitable for: WB, ELISA, IHC-Pmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide corresponding to Human ZMPSTE24 (C terminal) conjugated to Keyhole Limpet Haemocyanin (KLH).

  • Positive control
    • Formalin-fixed, paraffin-embedded human hepatocarcinoma tissue and T-47D cell lysate.



Our Abpromise guarantee covers the use of ab70952 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
  • Application notesELISA: 1/1000.
    IHC-P: 1/50 - 1/100.
    WB: 1/100 - 1/500. Detects a band of approximately 55 kDa plus a range of other bands. (predicted molecular weight: 55 kDa).

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionProteolytically removes the C-terminal three residues of farnesylated proteins. Acts on lamin A/C.
    • Tissue specificityWidely expressed. High levels in kidney, prostate, testis and ovary.
    • Involvement in diseaseDefects in ZMPSTE24 are the cause of mandibuloacral dysplasia with type B lipodystrophy (MADB) [MIM:608612]. Mandibuloacral dysplasia (MAD) is a rare autosomal recessive disorder characterized by mandibular and clavicular hypoplasia, acroosteolysis, delayed closure of the cranial suture, joint contractures, and types A or B patterns of lipodystrophy. Type B lipodystrophy observed in MADB, is characterized by generalized fat loss.
      Defects in ZMPSTE24 are a cause of lethal tight skin contracture syndrome (LTSCS) [MIM:275210]; also called restrictive dermopathy (RD). Lethal tight skin contracture syndrome is a rare disorder mainly characterized by intrauterine growth retardation, tight and rigid skin with erosions, prominent superficial vasculature and epidermal hyperkeratosis, facial features (small mouth, small pinched nose and micrognathia), sparse/absent eyelashes and eyebrows, mineralization defects of the skull, thin dysplastic clavicles, pulmonary hypoplasia, multiple joint contractures and an early neonatal lethal course. Liveborn children usually die within the first week of life. The overall prevalence of consanguineous cases suggested an autosomal recessive inheritance.
    • Sequence similaritiesBelongs to the peptidase M48A family.
    • Cellular localizationEndoplasmic reticulum membrane. Golgi apparatus membrane.
    • Information by UniProt
    • Database links
    • Alternative names
      • CAAX prenyl protease 1 homolog antibody
      • FACE-1 antibody
      • FACE1 antibody
      • FACE1_HUMAN antibody
      • Farnesylated proteins converting enzyme 1 antibody
      • Farnesylated proteins-converting enzyme 1 antibody
      • Prenyl protein specific endoprotease 1 antibody
      • Prenyl protein-specific endoprotease 1 antibody
      • STE24 antibody
      • Zinc metalloproteinase Ste24 homolog antibody
      • zmpste24 antibody
      see all

    Anti-ZMPSTE24 antibody - Carboxyterminal end images

    • Anti-ZMPSTE24 antibody - Carboxyterminal end (ab70952) at 1/100 dilution + T-47D cell lysate at 12.5 µg

      Predicted band size : 55 kDa
      Observed band size : 55 kDa
    • Formalin-fixed, paraffin-embedded human hepatocarcinoma tissue reacted with ab70952 at a 1:50 dilution. A peroxidase-conjugated secondary antibody was then used, followed by DAB staining.

    References for Anti-ZMPSTE24 antibody - Carboxyterminal end (ab70952)

    ab70952 has not yet been referenced specifically in any publications.

    Product Wall

    Application Immunocytochemistry
    Sample Human Cell (umbilical cord blood derived mesenchymal stem cell)
    Permeabilization Yes - 0.3% triton X-100
    Specification umbilical cord blood derived mesenchymal stem cell
    Blocking step normal goat serum as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 23°C
    Fixative Paraformaldehyde

    Abcam user community

    Verified customer

    Submitted Oct 20 2015